The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Placental Growth Factor, a Member of the VEGF Family, Contributes to the Development of Choroidal Neovascularization
Open accessAbstract
PURPOSE: VEGF has been shown to be necessary, but not sufficient alone, for the development of subretinal pathologic angiogenesis. In the current study, the influence of placental growth factor (PlGF), a member of the VEGF family, in human and experimental choroidal neovascularization (CNV) was investigated. METHODS: The presence of VEGF family member mRNA was evaluated by RT-PCR in neovascular membranes extracted during surgery. The spatial and temporal pattern of VEGF isoforms and PlGF mRNA expression were explored by using the laser capture catapulting technique and RT-PCR in a murine laser-induced model and in vitro. PlGF expression was also studied in human donor eyes. The influence of endogenous PlGF was evaluated in deficient mice (PlGF(-/-)) and by antibody-mediated neutralization of the PlGF receptor. RESULTS: Human neovascular membranes consistently expressed VEGF-A, -B, and -C; PlGF; and VEGFR-1 and -2. The VEGF(120) isoform mRNA was primarily induced in early stages of angiogenesis in vivo and in vitro. PlGF mRNA expression was present in the intact choroid and significantly upregulated during the course of experimental CNV. Both deficient PlGF expression in PlGF(-/-) mice and PlGF receptor neutralization in wild-type mice prevented the development of choroidal neovascularization induced by laser. CONCLUSIONS: These observations demonstrate the participation of PlGF in experimental CNV. They identify therefore PlGF as an additional promising target for ocular antiangiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Self-citationHageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Self-citationPierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,027
Grant, M. B., May, W. S., Caballero, S., Brown, G. A. J., Guthrie, S. M., Mames, R. N., Byrne, B. J., Vaught, T., Spoerri, P. E., Peck, A. B., et al. (2002) · Nature Medicine · doi:10.1038/nm0602-607 · Cited by 665
Kvanta, A., Algvere, P., Berglin, L., & Seregard, S. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70522-7 · Cited by 620
Krzystolik, M. G. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.338 · Cited by 590
Immunological and Aetiological Aspects of Macular Degeneration
Penfold, P. L., Madigan, M. C., Gillies, M. C., & Provis, J. M. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00025-2 · Cited by 460
Pe'er, J., Shweiki, D., Itin, A., Hemo, I., Gnessin, H., & Keshet, E. (1995) · PubMed · Cited by 422
THE EYETECH STUDY GROUP (2002) · Retina · doi:10.1097/00006982-200204000-00002 · Cited by 415
Spilsbury, K., Garrett, K. L., Shen, W.-Y., Constable, I. J., & Rakoczy, P. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64525-7 · Cited by 394
Retinal and choroidal neovascularization
Campochiaro, P. A. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200009)184:3<301::aid-jcp3>3.0.co;2-h · Cited by 393
Okamoto, N., Tobe, T., Hackett, S. F., Ozaki, H., Vinores, M. A., La Rochelle, W., Zack, D. J., & Campochiaro, P. A. (1998) · Retina · doi:10.1097/00006982-199805000-00034 · Cited by 365
Eggert, A., Ikegaki, N., Kwiatkowski, J. L., Zhao, H., Brodeur, G. M., & Himelstein, B. P. (2000) · PubMed · Cited by 353
Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors
Iruela-Arispe, L. M., & Dvorak, H. F. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657610 · Cited by 311
Miller, J. W., Adamis, A. P., & Aiello, L. P. (1997) · Diabetes / Metabolism Reviews · doi:10.1002/(sici)1099-0895(199703)13:1<37::aid-dmr174>3.0.co;2-k · Cited by 297
Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor
Cao, Y., Chen, H., Zhou, L., Chiang, M.-K., Anand-Apte, B., Weatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G., & Tsang, M. L.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3154 · Cited by 295
The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
Devy, L., Blacher, S., Grignet-Debrus, C., Bajou, K., Masson, V., Gerard, R. D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P. J., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0552com · Cited by 280
Self-citationPlacenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
Ziche, M., Maglione, D., Ribatti, D., Morbidelli, L., Lago, C. T., Battisti, M., Paoletti, I., Barra, A., Tucci, M., Parise, G., et al. (1997) · PubMed · Cited by 277
Ohno‐Matsui, K., Morita, I., Tombran‐Tink, J., Mrazek, D., Onodera, M., Uetama, T., Hayano, M., Murota, S., & Mochizuki, M. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10026 · Cited by 261
Persico, M. G. (2001) · Vascular Morphogenesis in the Female Reproductive System · doi:10.1007/978-1-4612-0213-4_16 · Cited by 259
Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes.
Kim, I. K., Ryan, A. M., Rohan, R. M., Amano, S., Agular, S., Miller, J. W., & Adamis, A. P. (1999) · PubMed · Cited by 243
Schwesinger, C., Yee, C., Rohan, R. M., Joussen, A. M., Fernandez, A., Meyer, T. N., Poulaki, V., Ma, J. J. K., Redmond, T. M., Liu, S., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64063-1 · Cited by 225
Vascular endothelial growth factor expression in choroidal neovascularization in rats
Yi, X., Ogata, N., Komada, M., Yamamoto, C., Takahashi, K., Omori, K., & Uyama, M. (1997) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf01739641 · Cited by 211
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert, R. E., Vranes, D., Wilkinson‐Berka, J. L., Kelly, D. J., Cox, A. J., Wu, L. L., Stacker, S. A., & Cooper, M. E. (1998) · PubMed · Cited by 179
Mori, K., Ando, A., Gehlbach, P. L., Nesbitt, D. J., Takahashi, K., Goldsteen, D., Penn, M., Chen, C. T., Mori, K., Melia, M. B., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61697-5 · Cited by 155
Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats.
Böcker-Meffert, S., Rosenstiel, P. C., Röhl, C., Warneke, N., Held‐Feindt, J., Sievers, J., & Lucius, R. (2002) · PubMed · Cited by 153
Quantitative Image Analysis of Laser-induced Choroidal Neovascularization in Rat
Edelman, J. L., & Castro, M. R. (2000) · Experimental Eye Research · doi:10.1006/exer.2000.0907 · Cited by 143
Increased expression of placenta growth factor in proliferative diabetic retinopathy.
Khaliq, A., Foreman, D., Ahmed, A., Weich, H. A., Gregor, Z. J., McLeod, D., & Boulton, M. E. (1998) · PubMed · Cited by 134
Grossniklaus, H. E. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01714-2 · Cited by 131
Otani, A., Takagi, H., Oh, H., Koyama, S., Ogura, Y., Matumura, M., & Honda, Y. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2407 · Cited by 128
Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization
Lambert, V., Munaut, C., Jost, M., Noël, A., Werb, Z., Foidart, J., & Rakic, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64401-x · Cited by 120
Self-citationEffects of Angiogenic Growth Factor Combinations on Retinal Endothelial Cells☆
Castellon, R., Hamdi, H., Sacerio, I., Aoki, A. M., Kenney, M. C., & Ljubimov, A. V. (2002) · Experimental Eye Research · doi:10.1006/exer.2001.1161 · Cited by 111
Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization
Lambert, V., Munaut, C., Noël, A., Frankenne, F., Bajou, K., Gerard, R. D., Carmeliet, P., Defresne, M. P., Foidart, J., & Rakic, J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0393com · Cited by 98
Self-citationWada, M., Ogata, N., Otsuji, T., & Uyama, M. (1999) · Current Eye Research · doi:10.1076/ceyr.18.3.203.5368 · Cited by 98
Liesegang, T. J. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01493-9 · Cited by 94
Expression of pigment epithelium-derived factor in experimental choroidal neovascularization.
Renno, R. Z., Youssri, A. I., Michaud, N. A., Gragoudas, E. S., & Miller, J. W. (2002) · PubMed · Cited by 77
Expression of the VEGF Gene Family during Retinal Vaso-Obliteration and Hypoxia
Simpson, D. A. C., Murphy, G. M., Bhaduri, T., Gardiner, T. A., ARCHER, D. B., & Stitt, A. W. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1201 · Cited by 72
Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig
Soubrane, G., Cohen, S. Y., Delayre, T., Tassin, J., Ollier-Hartmann, M. P., COSCAS, G. J., Courtois, Y., & Jeanny, J. (1994) · Current Eye Research · doi:10.3109/02713689408995776 · Cited by 50
Lu, D., Jimenez, X., Zhang, H., Wu, Y. L., Böhlen, P., Witte, L., & Zhu, Z. (2001) · PubMed · Cited by 49
Cited by
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Age-related macular degeneration
Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60282-7 · Cited by 1,717
Papadopoulos, N., Martin, J., Ruan, Q., Rafique, A., Rosconi, M. P., Shi, E., Pyles, E. A., Yancopoulos, G. D., Stahl, N., & Wiegand, S. J. (2012) · Angiogenesis · doi:10.1007/s10456-011-9249-6 · Cited by 1,037
Intravitreal Aflibercept for Diabetic Macular Edema
Korobelnik, J.-F., Do, D. V., Schmidt-Erfurth, U., Boyer, D. S., Holz, F. G., Heier, J. S., Midena, E., Kaiser, P. K., Terasaki, H., Marcus, D. M., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.006 · Cited by 816
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Liesenborghs, L., Koch, M., De Mol, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.038 · Cited by 779
Self-citation
Metadata
- Authors
- Rakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Noe¨l, A., & Munaut, C.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2003-07-01
- Volume
- 44
- Issue
- 7
- Pages
- 3186
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2154711032
- Cited by
- 321
- References
- 43
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.